Tofacitinib intermediate (3r, 4r) -1-benzyl-3- (methylomino) -4-methylperidine dihydrochloride; Cis 1-benzyl-4-methyl-3-methylomino piperidine dihydrochloride cas No. 1062580-52

Yedu tofacitinib intermediate inozivikanwawo seCis-benzyl-4-methyl-3-methylominopippiidine dihydrochloride uye ine cas nhamba 1062580-5-5-555-2. Iyo yepakati inyaya yakakosha mukugadzirwa kweTofacitinib, mushonga unoshandiswa kurapa rheumatoid arthritis, psoriatic arthritis uye ulcerative colitis. Sekiyi yepakati mumasendimendi eSynthesis yeTofacitinib, zvigadzirwa zvedu zvakakosha kune vanoongorora venhamba uye vagadziri.

Ichi chikamu chepakati chakanyatsojekesa kuti uve nechokwadi chekunaka kwakanyanya kwekuchena uye kusawirirana. Nezvedu-zve---e-art yekugadzira maitiro uye nzira yemhando yepamusoro yekudzora, iwe unogona kuvimba kuti yedu tofacitinib intermewordsasi inosangana neyemukati menesheni zviyero zvekuchena uye kugadzikana.

Tofacitinib intermediate (3r, 4r) -1-Benzyl-3- (mmemylomino) -4-mmemelomino) Kunyangwe iwe uri kuitisa chidzidzo chekutsvaga kana kuvandudza mishonga, makomputa edu epakati anopa mhinduro dzakavimbika uye dzinodhura-dzinobatsira kune zvaunoda chaizvo.